Phospho-FRA1 (Ser265) Antibody

Phospho-FRA1 (Ser265) Antibody

收藏
  • 询价
  • Cell Signaling Technology已认证
  • USA
  • 2025年07月15日
  • W, IP
  • Rabbit
  • H,M,R,Mk,B,Hr
avatar
品牌商
12钻石会员
  • 企业认证

    • 详细信息
    • 技术资料
    • 抗体英文名

      Phospho-FRA1 (Ser265) Antibody

    • 抗原

      synthetic phosphopeptide corresponding to Ser265 of the human FRA1 protein

    • 应用范围

      W, IP

    • 宿主

      Rabbit

    • 供应商

      CST

    • 级别

      详见MSDS文件

    • 适应物种

      H,M,R,Mk,B,Hr

    • 库存

      大量

    • 保质期

      详见说明书

    • 是否单克隆

      2

    • 保存条件

      -20°c

    • 规格

      100 ul (10 western blots)/carrier free & custom formulation / quantity

    规格:产品价格:¥请询价
    规格:100 ul (10 western blots)产品价格:¥请询价
    规格:carrier free & custom formulation / quantity产品价格:¥请询价

    pathway more info application references datasheet PDF MSDS PDF protocols

    Applications Key:  W=Western Blotting  IP=Immunoprecipitation
    Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey  B=Bovine  Hr=Horse
    Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

    Applications Reactivity Sensitivity MW (kDa) Source
    W IP H M R (Mk) (B) (Hr) Endogenous 40 Rabbit
    Protocols
    Specificity / Sensitivity

    Phospho-FRA1 (Ser265) Antibody detects endogenous levels of FRA1 protein only when phosphorylated on Ser265. This antibody also shows minor cross-reactivity with phospho-FRA2 and phospho-c-Fos, but does not cross-react with phospho-FosB.

    Source / Purification

    Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to Ser265 of the human FRA1 protein. Antibodies are purified by protein A and peptide affinity chromatography.

    Western Blotting

    Western Blotting

    Western blot analysis of extracts from HeLa cells, serum-starved overnight and TPA-stimulated for 4 hours, using Phospho-FRA1 (Ser265) Antibody #3880 (upper) and β-Actin Antibody #4967 (lower). Antibody phospho-specificity is shown by treating lysates with λ phosphatase.

    Background

    The Fos family of nuclear oncogenes includes c-Fos, FosB, Fos-related antigen 1 (FRA1), and Fos-related antigen 2 (FRA2) (1). While most Fos proteins exist as a single isoform, the FosB protein exists as two isoforms: full-length FosB and a shorter form, FosB2 (Delta FosB), that lacks the carboxy-terminal 101 amino acids (1-3). The expression of Fos proteins is rapidly and transiently induced by a variety of extracellular stimuli including growth factors, cytokines, neurotransmitters, polypeptide hormones, and stress. Fos proteins dimerize with Jun proteins (c-Jun, JunB, and JunD) to form Activator Protein-1 (AP-1), a transcription factor that binds to TRE/AP-1 elements and activates transcription. Fos and Jun proteins contain the leucine-zipper motif that mediates dimerization and an adjacent basic domain that binds to DNA. The various Fos/Jun heterodimers differ in their ability to transactivate AP-1 dependent genes. In addition to increased expression, phosphorylation of Fos proteins by Erk kinases in response to extracellular stimuli may further increase transcriptional activity (4-6). Phosphorylation of c-Fos at Ser32 and Thr232 by Erk5 increases protein stability and nuclear localization (5). Phosphorylation of FRA1 at Ser252 and Ser265 by Erk1/2 increases protein stability and leads to overexpression of FRA1 in cancer cells (6). Following growth factor stimulation, expression of FosB and c-Fos in quiescent fibroblasts is immediate, but very short-lived, with protein levels dissipating after several hours (7). FRA1 and FRA2 expression persists longer, and appreciable levels can be detected in asynchronously growing cells (8). Deregulated expression of c-Fos, FosB, or FRA2 can result in neoplastic cellular transformation; however, Delta FosB lacks the ability to transform cells (2,3).

    1. Tulchinsky, E. (2000) Histol. Histopathol. 15, 921-928.
    2. Dobrzanski, P. et al. (1991) Mol. Cell. Biol. 11, 5470-5478.
    3. Nakabeppu, Y. and Nathans, D. (1991) Cell 64, 751-759.
    4. Rosenberger, S.F. et al. (1999) J. Biol. Chem. 274, 1124-1130.
    5. Sasaki, T. et al. (2006) Mol. Cell 24, 63-75.
    6. Basbous, J. et al. (2007) Mol. Cell. Biol. 27, 3936-3950.
    7. Kovary, K. and Bravo, R. (1991) Mol. Cell. Biol. 11, 2451-2459.
    8. Kovary, K. and Bravo, R. (1992) Mol. Cell. Biol. 12, 5015-5023.
    Application References

    Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know !

    Companion Products

    For Research Use Only. Not For Use In Diagnostic Procedures.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥3662
    北京智杰方远科技有限公司
    2025年07月08日询价
    ¥4420
    杭州囊萤科技有限公司
    2025年06月20日询价
    询价
    美国CST中国公司(丁香通商铺)
    2024年10月09日询价
    询价
    南京赛戈巍生物科技有限公司
    2025年06月20日询价
    ¥4400
    武汉博欧特生物科技有限公司
    2025年03月03日询价
    Phospho-FRA1 (Ser265) Antibody
    询价